CHICAGO (GenomeWeb) – Pharmacogenomic informatics company OneOme has been chosen to interpret and package data for the Right 10K study, a collaboration between Mayo Clinic and the Baylor College of Medicine, the Minneapolis-based company said.

Right 10K is an effort to sequence 76 pharmacogenes from Mayo Clinic Biobank samples of 10,000 Mayo patients in order to assess the ability of PGx testing to improve long-term health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.